SciTransfer
Organization

OPTIMEDIS AG

German SME specializing in population health management, integrated chronic disease care, and clinical decision support systems for European healthcare.

Technology SMEhealthDESMENo active H2020 projects
H2020 projects
4
As coordinator
0
Total EC funding
€2.1M
Unique partners
75
What they do

Their core work

OptiMedis AG is a Hamburg-based healthcare management company specializing in population health management, integrated care models, and data-driven healthcare optimization. They bring real-world expertise in managing chronic disease populations and building clinical decision support systems that help healthcare providers deliver better outcomes at lower cost. Their work spans from big data analytics in healthcare to designing and evaluating self-management interventions for patients with complex chronic conditions.

Core expertise

What they specialise in

Population health managementprimary
3 projects

Central to BigMedilytics (healthcare big data), COMPAR-EU (chronic disease self-management), and ADLIFE (advanced chronic disease care).

2 projects

ADLIFE focuses on personalized empowerment platforms and clinical decision support; BigMedilytics applies big data to medical analytics.

Chronic disease care integrationprimary
2 projects

COMPAR-EU compares self-management interventions across 4 high-priority chronic diseases; ADLIFE targets patients with advanced chronic conditions.

1 project

BigMedilytics specifically focused on big data technologies for healthcare value generation and oncology applications.

Healthcare performance measurementsecondary
1 project

HealthPros trained a new generation of healthcare performance intelligence professionals.

Evidence synthesis and meta-analysisemerging
1 project

COMPAR-EU involved network meta-analysis to compare effectiveness of self-management interventions.

Evolution & trajectory

How they've shifted over time

Early focus
Healthcare big data analytics
Recent focus
Personalized chronic disease management

OptiMedis started their H2020 engagement in 2018 with a focus on healthcare big data analytics, oncology applications, and the industrialization of healthcare data (BigMedilytics, HealthPros). By 2020, their work shifted clearly toward personalized patient care — clinical decision support, self-management tools, and large-scale deployment of empowerment platforms for chronic disease patients (ADLIFE, COMPAR-EU). The trajectory shows a move from data infrastructure and analytics toward direct patient-facing digital health tools.

OptiMedis is moving from backend healthcare analytics toward deploying patient-facing digital health platforms at scale, making them increasingly relevant for projects requiring real-world implementation of integrated care solutions.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European19 countries collaborated

OptiMedis operates exclusively as a participant, never as coordinator — they contribute domain expertise rather than leading consortium management. With 75 unique partners across 19 countries from just 4 projects, they consistently join large, ambitious consortia (averaging ~19 partners per project). This pattern suggests they are a sought-after specialist partner valued for their applied healthcare management knowledge rather than their administrative capacity.

OptiMedis has built a broad European network of 75 unique partners across 19 countries through just 4 projects, indicating they consistently participate in large pan-European health consortia. Their network spans academic, clinical, and technology partners across most of the EU.

Why partner with them

What sets them apart

OptiMedis occupies a distinctive niche as a private SME that bridges healthcare management practice with EU research. Unlike academic partners who study health systems theoretically, OptiMedis brings operational experience in running integrated care models and population health programs. For consortium builders, they offer the rare combination of a company that both understands real-world healthcare delivery and can contribute to rigorous research design and evidence evaluation.

Notable projects

Highlights from their portfolio

  • COMPAR-EU
    Their largest funded project (EUR 733,796), comparing self-management interventions across 4 chronic diseases using network meta-analysis — directly applicable to healthcare policy decisions.
  • ADLIFE
    Their most recent project (2020-2024) targeting large-scale deployment of personalized care platforms for advanced chronic diseases, representing the practical implementation end of their expertise.
  • BigMedilytics
    Part of the EU's flagship big data initiative for healthcare, applying data analytics to oncology and population health — demonstrates their data science credentials.
Cross-sector capabilities
Digital health and health ITBig data analytics for healthcareEvidence-based policy supportTraining and capacity building in healthcare performance
Analysis note: Profile based on 4 projects (2018-2024), all as participant. The company's commercial healthcare management activities likely extend well beyond what is visible in H2020 data alone. No website URL was provided in the dataset, limiting verification of current service offerings. The keyword evolution analysis is meaningful but based on a small sample.